Evaluating Pelvic Floor Dysfunction in Female Horse Show Jumpers Using the Australian Pelvic Floor Questionnaire

16 March 2025 : Clinical Research

Anna Katarzyna Cygańska

^{ABCDEFG 1*}, Blanka Giżewska^{ABCDEF 1}, Kinga Zdunek^{DE 2}

DOI: 10.12659/MSM.946830

Med Sci Monit 2025; 31:e946830

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Results of the APFQ questionnaire by group (M, SD, 95% Cl, effect size).

Variable	Group In=55	Group IIn=19	Control groupn=86	p-Value	Effect size (η2; Cohen’s f)
Bladder function	0.93 (0.85)0.69–1.16	0.88 (0.66)0.55–1.20	0.88 (0.67)0.73–1.02	0.901	0.000	0.004
Bowel function	1.22 (0.96)0.96–1.48	1.38 (0.93)0.93–1.82	1.37 (0.77)1.20–1.53	0.266	0.000	0.012
Prolapse symptoms	0.02 (0.13)−0.01–0.06	0.00	0.04 (0.19)0.00–0.08	0.626	0.003	0.051
Sexual function	n=441.68 (1.69)1.16–2.19^*	n=171.46 (1.23)0.82–2.1^*	n=691.80 (1.40)1.47–2.14^*	0.515	0.004	0.063
Total score for sexually inactive	n=443.84 (2.68)3.03–4.66	n=173.82 (1.86)2.87–4.78	n=694.19 (2.09)3.69–4.69	0.460	0.001	0.024
Total score for sexually active	n=112.20 (1.39)1.26–3.13	n=21.33 (1.88)−15.53–18.19	n=171.86 (0.69)1.50–2.22	≤0.834	0.050	0.231
^* Values given for sexually active group; Kruskal-Wallis test.

Back to the Article